About this trial
Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation.
The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.
Eligibility criteria
Qualifiers
healthy adults
ages 18-65
no underlying chronic disease or acute conditions
no autoimmune conditions
Disqualifiers
not have been clinically diagnosed with depression
not taking antidepressants, anxiety, or stress medications, or any other medications
drugs, or supplements that could influence mental capacities
not pregnant or breastfeeding
Trial design
Treatments tested in this trial
- Spirulina capsules
- Placebo